World Health Organization

Technical summary

Primary sponsor of the WHO Immediate KMC Study (ANZCTR, ICTRP) and issuer of the 2022 guideline on care of the preterm or low-birth-weight infant. It also issued postpartum haemorrhage guidance: the 2017 recommendation on tranexamic acid for treatment, the 2023 recommendations on assessing blood loss and on a treatment bundle, and the 2025 consolidated guideline on prevention, diagnosis and treatment. The institution role is a placeholder that the schema requires.